What we do
Corporate Governance Advisory Services
ESG Advisory Services
M&A and Information Agent Services
Capital Market Intelligence Services
Proxy Contests, Hostile Takeovers & Shareholder Activism Services
Proxy Solicitation and Shareholder Meeting Services
Retail Services and Additional Capabilities
Board of Director Services
Debt Services
SPAC Advisory Services
Services for Registered Funds - Mutual Funds, Exchange Traded Funds (ETFs) and Closed-End Funds - Di Costa Partners
Client Portal

Recent Mergers and Acquisitions

Celgene Corporation merger with Bristol-Myers Squibb

Celgene Corporation, an immunology pharmaceutical company, merged with Bristol-Myers Squibb (NYSE: BMY), a prescription-manufacturing pharmaceutical company, in a transaction valued at $74 billion.

Morrow Sodali acted as the proxy solicitor for the bidder in this transaction.

Find more information here.

Topics

Celgene Corporation merger with Bristol-Myers Squibb

Topics

Celgene Corporation, an immunology pharmaceutical company, merged with Bristol-Myers Squibb (NYSE: BMY), a prescription-manufacturing pharmaceutical company, in a transaction valued at $74 billion.

Morrow Sodali acted as the proxy solicitor for the bidder in this transaction.

Find more information here.

© 2016 - 2022 Morrow Sodali